97 related articles for article (PubMed ID: 7961004)
1. The role of lymphangiography in designing fields for elective pelvic node irradiation in Hodgkin's disease.
Mendenhall NP; Holland KW; Sombeck MD
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):993-5. PubMed ID: 7961004
[TBL] [Abstract][Full Text] [Related]
2. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy.
Bonin SR; Lanciano RM; Corn BW; Hogan WM; Hartz WH; Hanks GE
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):167-72. PubMed ID: 12118547
[TBL] [Abstract][Full Text] [Related]
3. [Standard versus individually planned irradiation field in radiotherapy of infradiaphragmatic lymph node sites].
Nevinny-Stickel M; Ennemoser S; Bangerl I; zur Nedden D; Lukas P
Strahlenther Onkol; 1998 Jul; 174(7):341-4. PubMed ID: 9689953
[TBL] [Abstract][Full Text] [Related]
4. Comparison of standard and individually planned infradiaphragmatic fields in irradiation of retroperitoneal lymph nodes.
Nevinny-Stickel M; Ennemoser S; Sweeney R; Bangerl I; Zur Nedden D; Lukas P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):147-51. PubMed ID: 10924984
[TBL] [Abstract][Full Text] [Related]
5. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks.
Finlay MH; Ackerman I; Tirona RG; Hamilton P; Barbera L; Thomas G
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):205-9. PubMed ID: 16198505
[TBL] [Abstract][Full Text] [Related]
6. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.
Shih HA; Harisinghani M; Zietman AL; Wolfgang JA; Saksena M; Weissleder R
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1262-9. PubMed ID: 16253781
[TBL] [Abstract][Full Text] [Related]
7. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):13-8. PubMed ID: 8823254
[TBL] [Abstract][Full Text] [Related]
8. Competing irradiation techniques for para-aortic lymph nodes: dose distribution and NTCP for the kidney.
Nevinny-Stickel M; Seppi T; Poljanc K; Forthuber BC; Posch A; Lechner J; Ulmer H; Sweeney R; Saurer M; Lukas P
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1206-13. PubMed ID: 15978740
[TBL] [Abstract][Full Text] [Related]
9. Topographic distribution of inguinal lymph nodes metastasis: significance in determination of treatment margin for elective inguinal lymph nodes irradiation of low pelvic tumors.
Wang CJ; Chin YY; Leung SW; Chen HC; Sun LM; Fang FM
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):133-6. PubMed ID: 8641909
[TBL] [Abstract][Full Text] [Related]
10. Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer.
Pendlebury SC; Cahill S; Crandon AJ; Bull CA
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):959-62. PubMed ID: 8244829
[TBL] [Abstract][Full Text] [Related]
11. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
Goldsmith B; Baumann BC; He J; Tucker K; Bekelman J; Deville C; Vapiwala N; Vaughn D; Keefe SM; Guzzo T; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):603-10. PubMed ID: 24411628
[TBL] [Abstract][Full Text] [Related]
12. The impact of pelvic recurrence and elective pelvic irradiation on survival and treatment morbidity in early-stage Hodgkin's disease.
Mendenhall NP; Taylor BW; Marcus RB; Million RR
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1157-65. PubMed ID: 1938513
[TBL] [Abstract][Full Text] [Related]
13. Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins.
Kershaw L; van Zadelhoff L; Heemsbergen W; Pos F; van Herk M
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):68-77. PubMed ID: 29051038
[TBL] [Abstract][Full Text] [Related]
14. Lymphangiography. Its practical value in surgically staged patients with Hodgkin's disease.
Kadin MR; Thompson RW
West J Med; 1974 Mar; 120(3):193-9. PubMed ID: 4816398
[TBL] [Abstract][Full Text] [Related]
15. CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients.
Yousefi Kashi AS; Khaledi S; Houshyari M
Iran J Cancer Prev; 2016 Jun; 9(3):e6233. PubMed ID: 27703649
[TBL] [Abstract][Full Text] [Related]
16. Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning.
Marnitz S; Köhler C; Schneider A; Seiler F; Hinkelbein W
Strahlenther Onkol; 2006 Feb; 182(2):80-5. PubMed ID: 16447014
[TBL] [Abstract][Full Text] [Related]
17. Calcification in pelvic lymph nodes containing Hodgkin's disease following radiotherapy.
McLennan TW; Castellino RA
Radiology; 1975 Apr; 115(1):87-9. PubMed ID: 1118624
[TBL] [Abstract][Full Text] [Related]
18. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
19. Changes in the size of pelvic lymph nodes in patients being followed after radiotherapy for Hodgkin's disease.
Williams MV; Macdonald JS; Peckham MJ
Clin Radiol; 1980 Sep; 31(5):545-50. PubMed ID: 7471629
[TBL] [Abstract][Full Text] [Related]
20. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
